Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6941-6950 of 13616

Page
per page
  1. Voxtalisib
    C9073 Voxtalisib
    Summary: A small-molecule PI3K/mTOR dual inhibitor for in vitro signal transduction research.
  2. ICP 103
    A8801 ICP 103
    Summary: A highly selective protein kinase C (PKC) inhibitor that inhibits PKC signaling, for immune, anti-tumor, and inflammatory pathways.
      insoluble in EtOH; insoluble in H2O; ≥16.2 mg/mL
  3. PTP1B-IN-2
    B8544 PTP1B-IN-2
    Summary: A potent and selective protein tyrosine phosphatase-1B (PTP1B) inhibitor
      ≥49.3 mg/mL
  4. EGFR Inhibitor
    C3327 EGFR Inhibitor
    Summary: EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60.7 mg/mL
  5. α-Zearalenol
    C3405 α-Zearalenol
    Summary: estrogen receptor agonist
      ≤20 mg/mL
  6. Iso-Olomoucine
    C3767 Iso-Olomoucine
    Summary: inactive stereoisomer of the Cdk5 inhibitor olomoucine
      ≤0.3 mg/mL
  7. Indomethacin heptyl ester
    C4718 Indomethacin heptyl ester
    Summary: non-selective inhibitor of both COX-1 and COX-2
      ≤17 mg/mL
  8. Oxamflatin
    B7796 Oxamflatin
    Summary: HADC inhibitor
      Soluble in DMSO
  9. DL-threo-2-methylisocitrate sodium
    B1310 DL-threo-2-methylisocitrate sodium
    Summary: Substrate of isocitrate lyase 1(ICL1)
      Soluble in DMSO
  10. Vancomycin hydrochloride
    B1223 Vancomycin hydrochloride
     1 Citation
    Target: Antibiotic
    Summary: glycopeptide antibacterial agent
      ≥55.8 mg/mL

Items 6941-6950 of 13616

Page
per page